Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them ; day:25 ; month:6 ; year:2019 ; pages:1-17
Clinical pharmacokinetics ; (25.6.2019), 1-17
- Creator
-
Peters, Sheila Annie
Dolgos, Hugues
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-019-00790-0
- URN
-
urn:nbn:de:101:1-2019092501441506192768
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.06.2007, 7:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Peters, Sheila Annie
- Dolgos, Hugues
- SpringerLink (Online service)
Other Objects (12)
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments